SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics ($CAPR) is trending due to positive phase 3 data for its Duchenne muscular dystrophy treatment, sending shares soaring and sparking discussions of accelerated approval. The community is buzzing about a potential short squeeze, citing high short interest and borrow fees, while also speculating on buyout possibilities and future indications for the company's technology. Some traders are booking profits while others are anticipating further upside, fueled by analyst upgrades and potential expansion into new markets.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

CVNA is trending as the stock price defies broader market concerns, with retail traders actively debating its valuation and potential for a short squeeze. Community discussions revolve around the company's fundamentals versus market momentum, with some pointing to insider selling and high debt levels, while others highlight potential for further gains. The stock's volatile price action and potential S&P 500 inclusion are also key talking points.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), Global Services (BGS), and Boeing Capital (BCC). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The Boeing Capital segment seeks to ensure that Boeing customers have the financing they need to buy and take delivery of their Boeing product and manages overall financing exposure. The company was founded by William Edward Boeing on July 15, 1916 and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is trending as the FTC requires the company to divest Spirit assets for its merger, sparking community debate about its impact. Some traders see the dip as a buying opportunity, while others express concern over the company's ability to hold gains and the ongoing regulatory scrutiny. The discussion includes broader concerns about cash flow and production relative to future earnings expectations.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Galectin Therapeutics is trending as the community discusses potential FDA feedback on submitted data, with anticipation building around potential next steps for belapectin. Community members are pointing to positive biomarker data and highlighting CEO Joel Lewis's increased excitement, speculating about potential partnerships or a possible buyout. Investors are also actively monitoring short positions and overall trading volume.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors discuss the potential impact of Marvell's acquisition of Celestial AI, a key partner, on POET's sales outlook and technology validation. The community highlights POET's unique optical interposer technology and patent portfolio, speculating on potential licensing agreements or even a full acquisition. Discussions also focus on the recent high trading volume and the possibility of a rebound to previous price levels.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as traders discuss potential catalysts including upcoming ACA subsidy news and the DOJ ruling. The community is analyzing technical indicators, with some anticipating a rise to $340 and beyond, while others remain skeptical about the stock's short-term performance. Broader market factors, like the rotation from tech stocks, are also being considered in relation to UNH's movements.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending amidst discussions about AI sales targets and its partnership with Anthropic, with some questioning if the company revised targets. Community talking points revolve around the validity of news reports and potential market manipulation, with some suggesting the stock is oversold given Microsoft's broader market position. The conversation also includes the competitive landscape in AI, particularly regarding Microsoft's Copilot versus offerings from Google and Palantir.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

Crowdstrike is trending as analysts update price targets following recent performance, with community members discussing technical levels and potential upside. Bullish sentiment is fueled by the cybersecurity firm's strong position in the market and AI-driven capabilities, though some debate its valuation. The stock's ability to hold key moving averages is a focal point for many traders.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending due to a mix of factors including earnings results, a potential acquisition, and shifts in analyst ratings. Community discussions revolve around the company's AI infrastructure play and its move into optical interconnects with the possible acquisition of Celestial AI. Some traders are eyeing shorting opportunities amidst concerns of an overvalued stock, while others remain bullish on Marvell's long-term growth potential in the AI sector.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending as investors anticipate the upcoming earnings report, focusing on the company's potential in the AI-driven 'agentic automation' space. Community members are actively discussing potential price movements post-earnings, with some expressing concerns about historical patterns of pre-earnings run-ups followed by sell-offs. Many bulls believe UiPath's partnerships and strong financials position it for significant growth, while others remain cautious due to the stock's past performance and ongoing debates about its valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


VETS
Pet DRx Corporation

Feed

News

Sentiment

Fundamentals

Info

Latest VETS News

VETSPet DRx Corporation